Editas Medicine, Inc.
EDIT
$2.22
-$0.13-5.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -76.09M | -45.40M | -62.14M | -67.61M | -61.95M |
| Total Depreciation and Amortization | 1.92M | 1.38M | 1.60M | 1.42M | 1.41M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.76M | 5.35M | 3.62M | 2.72M | 5.87M |
| Change in Net Operating Assets | 17.62M | -12.10M | 4.34M | 6.41M | 4.80M |
| Cash from Operations | -47.80M | -50.76M | -52.59M | -57.06M | -49.87M |
| Capital Expenditure | -114.00K | -540.00K | -2.92M | -3.49M | -1.87M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.50M | 31.50M | 86.90M | 55.45M | -2.87M |
| Cash from Investing | 56.39M | 30.96M | 83.98M | 51.95M | -4.75M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.44M | 269.00K | 0.00 | 322.00K | 192.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.87M | 55.24M | -- | -- | -- |
| Cash from Financing | -1.44M | 55.51M | 0.00 | 322.00K | 192.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.15M | 35.71M | 31.39M | -4.79M | -54.43M |